Monday, May 10, 2021 8:34:44 AM
Was in XXII many years ago prior to when it had the big run-up, didn't sell until it dropped back way down, but have been following it ever since. Knew one day it would be big. In another stock now that looks like it should do nicely soon and, if so, most likely will get back in XXII. Why?
I think stockholders here have even more value tied up in hemp than they do in tobacco, and the value in tobacco alone is HUGE. It also looks like it will be able to realize the value in tobacco in a very short time IMO.
XXII has been fighting big tobacco just like my stock has been fighting big pharma. You can't tell me the govt needs to evaluate low nicotine cigarettes to the tune of 35MM cigs/yr for about 10-15 years now and still can't make a decision to go/no go. Some big payola has been keeping XXII down IMO.
Hemp should become the biggest crop in the world due to it's many uses and ease of growing. XXII should be able to capture both the medical side advantages and the industrial side ones as well. It should be able to turn many 3rd world economies around IMO. Rooting for you stockholders to hit it big.
I will keep watching but wanted to congratulate those that have stayed in XXII, or recently found XXII, as it could/should be a world changing opportunity IMO.
I think stockholders here have even more value tied up in hemp than they do in tobacco, and the value in tobacco alone is HUGE. It also looks like it will be able to realize the value in tobacco in a very short time IMO.
XXII has been fighting big tobacco just like my stock has been fighting big pharma. You can't tell me the govt needs to evaluate low nicotine cigarettes to the tune of 35MM cigs/yr for about 10-15 years now and still can't make a decision to go/no go. Some big payola has been keeping XXII down IMO.
Hemp should become the biggest crop in the world due to it's many uses and ease of growing. XXII should be able to capture both the medical side advantages and the industrial side ones as well. It should be able to turn many 3rd world economies around IMO. Rooting for you stockholders to hit it big.
I will keep watching but wanted to congratulate those that have stayed in XXII, or recently found XXII, as it could/should be a world changing opportunity IMO.
Recent XXII News
- 22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine Cigarettes • GlobeNewswire Inc. • 05/21/2026 11:00:00 AM
- 22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. Retailers • GlobeNewswire Inc. • 05/18/2026 01:00:00 PM
- 22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand • GlobeNewswire Inc. • 05/15/2026 12:37:00 PM
- 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review • GlobeNewswire Inc. • 05/12/2026 05:50:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 10:30:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:06:10 AM
- 22nd Century Group Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 10:00:00 AM
- 22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026 • GlobeNewswire Inc. • 05/04/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 09:20:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/01/2026 09:15:15 PM
- 22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership • GlobeNewswire Inc. • 04/29/2026 08:35:00 PM
- 22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University • GlobeNewswire Inc. • 04/23/2026 11:50:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:24 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:35:13 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:30:36 PM
- 22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 09:00:54 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/27/2026 08:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:02:51 PM
- 22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 10:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 05:57:09 PM
- 22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:14:20 PM
- 22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products • GlobeNewswire Inc. • 02/23/2026 10:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:15:28 PM
